How to Choose an Oncology CRO: A Practical RFP Guide for Sponsors and Biotech Teams

What You’ll Learn in This Article

Table of Contents

This guide is here to help. Whether you’re leading clinical operations, overseeing R&D, or managing a growing biotech pipeline, it will walk you through what to look for in an oncology CRO, the questions that matter most during selection, and common mistakes to avoid. The goal is simple: give you a clear, practical framework for choosing a CRO that’s ready to meet the real-world demands of oncology trials. 

Key Challenges in Oncology Trials and What to Expect from Your Oncology CRO 

Oncology trials come with distinctive challenges that affect trial execution. Sponsors should recognize these upfront, as they inform what to seek in a CRO partner. Key challenges include: 

Challenge Area	Why It Matters in Oncology Trials	What to Look for in an Oncology CRO
Narrow Patient Populations & Enrollment Hurdles	Oncology trials target specific subgroups by tumor type, stage, or biomarker. Only ~5–6% of adult cancer patients enroll in trials. Patients may be dispersed, and multiple trials often compete for the same populations.	Look for CROs with experience in rare and hard-to-reach populations, strong site relationships, and creative recruitment tactics like referral networks and concierge services.
Biomarker Requirements & Complex Protocols	Many studies require central lab testing, complex assays, and adaptive designs like basket or umbrella trials. These increase site and patient burden, risk protocol deviations, and demand real-time data coordination.	Choose a CRO with deep operational expertise in biomarker logistics, tissue handling, and adaptive trial execution. They should have strong data management and site support processes.
Evolving Standards and Frequent Changes	Oncology trials often face mid-study amendments due to new therapies, regulatory shifts, or emerging scientific insights. This requires fast protocol updates and IRB re-approvals across regions.	A capable oncology CRO must be nimble, with proven processes for handling protocol amendments and deep knowledge of global regulatory pathways. Statistical fluency is a plus.

These challenges, scarce patients, biomarker complexity, adaptive designs, and more, underscore why choosing a CRO with genuine oncology expertise is so important. A qualified oncology CRO will have strategies to mitigate enrollment barriers, ensure biomarker and data management excellence, and adapt to change so your trial stays on track. 

What to Really Look for in an Oncology CRO: 7 Sponsor-Centered Criteria That Matter

Not all CROs are built for oncology. Glossy brochures and big names don’t guarantee performance. If you’re a sponsor evaluating oncology CROs, here are seven practical things to focus on — the kind that actually affect timelines, quality, and outcomes. 

• Real Oncology Experience

Ask how many oncology trials they’ve run recently. In your indication? Phase I? Biomarker-based? Don’t just accept “yes, we do oncology.” Look for depth — from adaptive trial experience to managing rare cancers — and proof they’ve delivered. Ask about publications, submissions, and regulatory wins. 

• Smart Data and Tech Capabilities

Oncology trials create a ton of complex data: imaging, biomarkers, adverse events. You want a CRO that uses reliable EDC platforms, real-time dashboards, and tools like ePRO and remote monitoring. They should integrate lab and genomic data smoothly — and keep it all secure and compliant. 

• Site Networks and Global Reach

Enrollment is hard in oncology. The right CRO already knows which sites enroll, how to activate them fast, and how to handle global regulatory differences. Ask for track records — how fast did they enroll 50 patients in a similar study? Do they partner with advocacy groups or referral networks? 

• Patient-Centric Thinking

This isn’t about buzzwords — it’s about real actions. Can patients do visits from home? Will the CRO offer flexible scheduling or travel help? Do they think about diversity, burden, and keeping people in the study? Trials only work if patients can stick with them. 

• Quality and Compliance

Oncology trials come under serious regulatory scrutiny. Ask if the CRO has passed FDA or EMA inspections. How do they handle safety reports, SAEs, and protocol changes? Their team should be trained specifically in oncology and up to date with evolving regulations (like EU CTR and CTIS). 

• Project Execution and Responsiveness

Who will run your trial day to day? Ask for names. You need experienced oncology project managers, not generalists. Ask how they escalate issues, how often they update you, and how they handle surprises — like slow sites or protocol amendments. Execution matters more than promises. 

• Flexibility and Fit

Lastly, can they adapt to you? Rigid processes or surprise change orders can derail collaboration fast. Look for a CRO that offers flexible service models and clear change management. You want a team that’s collaborative, not transactional — especially if you’re a smaller sponsor. 

Pro tip: Any CRO can say “we’re experienced” or “patient-focused.” Your job is to ask questions that reveal what’s behind the buzzwords. In the next section, we’ll cover exactly which RFP questions help separate talk from track record. 

Actionable RFP Questions for Choosing the Right Oncology CRO

A strong RFP helps you look past sales decks and uncover how a CRO actually works. Below are practical questions that reveal a CRO’s real-world oncology capabilities, and how well they’ll execute your study. 

What to Ask	Why It Matters
“What’s your experience in our cancer type and trial phase?”	Forces the CRO to go beyond general claims and cite relevant case studies or metrics. Ask for outcomes, not just participation.
“Who will be on our actual project team?”	Avoid the bait-and-switch. Insist on knowing who’s assigned and their oncology background. Ask how team continuity is ensured.
“How would you approach recruitment and site selection for our study?”	A strong oncology CRO should offer a specific plan based on networks, data, and referral strategies — especially for hard-to-enroll populations.
“How do you manage protocol amendments or scope changes?”	Oncology trials often shift mid-stream. Ask how fast they implement changes across systems, sites, and budgets.
“How do you handle oncology-specific data and endpoints?”	Tumor response, imaging, biomarkers — it’s complex. Ask about their data tools, dashboards, and how they track real-time insights.
“What patient-centric approaches do you offer?”	Look for specific steps: home visits, telehealth, travel support, eConsent, or retention strategies. Don’t settle for buzzwords.
“How will your team communicate with ours?”	Ask about cadence, tools, escalation process, and how they tailor collaboration to companies of your size and structure.
“What sets your oncology execution apart from others?”	Give them a chance to show innovation. Look for unique infrastructure, partnerships, or differentiators that go beyond “experience.”
“Can you share references or recent oncology performance metrics?”	If possible, speak with past clients — or ask for anonymized KPIs (e.g. enrollment speed, protocol adherence, on-time delivery rates).

 

Tip: Don’t just evaluate what they say, watch how they respond. A partner with strong oncology execution will be transparent, thoughtful, and responsive in every conversation. 

Common Pitfalls in Selecting an Oncology CRO (and How to Avoid Them)

Even experienced sponsors make mistakes when selecting an oncology CRO. Here are five common ones — and how to steer clear of them. 

1. Sticking with your usual CRO out of habit
   Just because a CRO worked for a past trialdoesn’t mean they’re the right fit for your oncology study. Every program is different. 
   Avoid it: Always do a market check or short list for new trials. Don’t skip due diligence. 
2. Choosing a big-name CRO just for the brand
   Large CROs offer scale, but smaller sponsors often get lower priority. You may not get the team you werepitched. 
   Avoid it: Ask to meet the actual team. Include named resources in your contract. Consider mid-sized CROs that treat your trial as a priority. 
3. Overweighting oncology experience over execution
   Knowing yourindication doesn’t guarantee good delivery. Some CROs struggle with basics like timelines, communication, and data quality. 
   Avoid it: Look at both experience and past results. Ask for examples of how they handled real challenges — not just their disease knowledge. 
4. Picking the lowest bid
   Cheap bids often miss hidden costs. In oncology, complexity meanschange orders can pile up fast. 
   Avoid it: Compare total cost, not just initial price. Ask about their scope change process and how they’ve handled budget shifts in past trials. 
5. Falling for the “A-team” bait-and-switch
   You meet great people during the pitch — then a different team shows up after contract signature.
   Avoid it: Lock in named team members contractually. Ask for references that speak to team consistency, not just CRO reputation. 

By being aware of these pitfalls, you can proactively address them during selection and contracting. The overarching theme is due diligence: verify claims, trust but verify the team, and don’t rush into a decision based on comfort, price, or a slick presentation alone. Oncology trials are too important to risk on a mismatched partnership. 

Choosing the Right Oncology CRO: What Really Matters

Picking an oncology CRO isn’t just a vendor decision, it directly impacts trial success. Oncology trials are complex, fast-moving, and high-stakes. That’s why sponsors need partners with deep oncology experience, strong execution, patient-first thinking, and the flexibility to adapt as trials evolve. 

Ask hard questions. Look beyond slide decks. The right CRO doesn’t just run your study, they help you deliver for patients. 

At Cromos Pharma, we bring hands-on oncology trial experience across phases and indications. Our model is built around sponsor needs, not rigid packages. We focus on patient-centered execution, flexible operations, and high-quality results, without slow processes or “pay-first” structures. 

If your oncology program demands speed, focus, and partnership, we’re built for that.